2004 – 2011 UTsouthwestern Medical Center at Dallas, Genetics & Development, PhD, Postdoc
1999 – 2003 Peking University, Collage of Life Sciences, Bachelor
2019-present Assistant Investigator，Chinese Institute for Brain Research, CIBR, Beijing, China
2014 – 2019 Professor，Soochow University, Institute of Functional Nano and Soft Materials,
2012 – 2014 Director，Origene Technologies, Senior Scientist
Glioblastoma is one of the most malignant tumors, and after decades of research, treatment regimens for glioma patients are still limited to surgery, radiotherapy and chemotherapy regimens, while the survival of glioblastoma patients is still only more than 10 months old. Our previous studies have shown that gliomas are likely to originate from adult neural stem cells that have the ability to renew themselves. In an established malignant glioma, there are some tumor cells that express stem cell markers, which are very important for the tumor’s resistance to chemotherapy and tumor recurrence.
By utilizing mouse genetics, primary (tumor) cell culture, we are trying to understand key components that drives malignant transformation or responsible for tumor maintenance. We are also interested in the unique relationship between the immune system and brain microenvironment. Meanwhile, we are exploring the use of small molecules, CAR-T and tumor lytic virus for tumor progression intervention.